China's regulatory rumours hit Blackmores

Blackmores says its full-year net profit tumbled 41 per cent to $59 million as sales were hit by speculation of regulatory changes in China.

Blackmores natural remedy products

Blackmores' full-year net profit has tumbled 41 per cent to $59m on the back of a decline in sales. (AAP)

Vitamin maker Blackmores' full year profit has tumbled as regulatory rumours dampened demand from Chinese consumers in Australia.

Chief executive Richard Henfrey said talk of potential changes to China's e-commerce regulations and "the suitcase trade" had impacted the buying patterns of Chinese entrepreneurs and tourists who were previously purchasing products in Australian stores and taking them back home.

The reduction was significant and came without warning, the company said, particularly in the first quarter of the financial year, and dragged full year profit for 2016/17 down 41 per cent to $59 million.

Blackmores made a record profit of $100 million in 2015/16 and estimated that more than $200 million of its total $717 million revenue came from Chinese consumers as visitors took products home.

Mr Henfrey, who replaced Australia Post-bound Christine Holgate less than two weeks ago, said regulatory changes never came about, but rumours about them created a great deal of uncertainty in the market.

"Those Australian-Chinese consumers stopped buying at that point of time and we have worked pretty hard to recover from that," Mr Henfrey told AAP on Tuesday.

Full year revenue from ordinary activities fell three per cent to $693 million, with the bulk of sales coming from the company's Australian and New Zealand arm, despite a 23 per cent drop compared to a year ago.

Excluding the impact of Chinese influenced sales, branded domestic sales were in line with the prior year.

Asia direct sales rose 36 per cent to $216 million, amid growing demand for products in China, where direct sales grew 71 per cent to $132 million.

Blackmores' BioCeuticals Group, which includes the BioCeuticals and Global Therapeutics brands, also lifted its sales, to $102 million.

The vitamin maker said it had increased its inventory provisions from $2 million to $14 million to protect against possible future uncertainty, which had impacted earnings by around $10 million for the full year.

It said it expects regulation, pricing and evolving market conditions to continue to provide challenges in the year ahead but, notwithstanding these challenges, believes its Asia division, particularly China, will strengthen.

Blackmores shares gained $6.82, or 7.5 per cent, to $97.99.

AUST SALES SLUMP HITS BLACKMORES PROFIT:

* Full year net profit down 41pct to $59m

* Revenue down 3pt to $692.8m

* Final dividend down 70 cents to $1.40, fully franked


Share

3 min read

Published

Source: AAP



Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world